Results

Total Results: 1,482 records

Showing results for "indication".
Users also searched for: medication reconciliation

181. palliative-care-protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-tools_research-protocol.pdf
     April 14, 2016 - palliative-care-protocol                 Evidence-based Practice Center Technical Brief Protocol Project Title: Assessment Tools for Palli…

182. Dyspnea DEcIDE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea_research.pdf
     April 01, 2010 - Dyspnea DEcIDE The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that support the rapid development of new scientific information and analytic tools. The DEcIDE network assists healt…

183. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
     March 01, 2012 - Amgen requests that the complete indication, as specified in the Prolia® prescribing information, be … Inclusion of this full indication would provide a more complete characterization of the intended patient … We have added the full indication. … changes were nearly identical to the changes in women, and the drug was approved in men with the indication … The PMO study in women did show the effect of both vert and non-vert reduction and that is the indication

184. Medical Therapies for Children With Autism Spectrum Disorder—An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-executive-170505.pdf
     May 01, 2017 - across studies; some studies amply described how harms were tracked, while others listed harms with no indication … across studies; some studies amply described how harms were tracked, while others listed harms with no indication

185. Undescended-Testicle Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
     December 01, 2012 - Four studies provided data on LHRH compared with hCG, with no clear indication of either being better … Across all KQs, there is no indication that study populations are different from those in standard

186. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - patients with CF are homozygous for that mutation, giving ivacaftor the potential for a much broader indication … G551S, G970R, G1244E, S1251N, S1255P, and G1349D.8,9 Thus, ivacaftor may gain a broader patient indication

187. Ch 1-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
     August 13, 2012 - randomization might be needed, such as determining whether an FDA-approved drug can be used for a new use or indication … In this case, the FDA revoked their approval of the breast cancer indication for Avastin after concluding

188. Systematic Review of Intermittent Inhaled Corticosteroids and of Long-acting Muscarinic Antagonists for Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-pharmacologic-treatment_research-protocol.pdf
     December 27, 2016 - muscarinic antagonists Class Registered/Trademark (chemical name) Regulatory Agency Approved Indication … September 14, 2016; republished December 27, 2016 17 Class Registered/Trademark (chemical name) Indication

189. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
     January 01, 2012 - month) when first approved for opioid addiction treatment, but reports of slow adoption for this indication … market. 24 According to the drug’s prescribing information, extended-release naltrexone for this indication

190. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - Layout 1 Background Depressive disorders such as major depressive disorder (MDD), dysthymia, and subsyndromal depression (including minor depression) may be serious disabling illnesses. MDD is the most prevalent, affecting more than 16 percent (lifetime) of U.S. adults. In 2000, the U.S. economic burden of depressiv…

191. Topic 0614 Tonsillectomy NSD FINAL CC (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0768-141211.pdf
     October 23, 2014 - Topic 0614 Tonsillectomy NSD FINAL CC Tonsillectomy for Recurrent Infection and Sleep Disordered Breathing Nomination Summary Document Results of Topi…

192. Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research.pdf
     June 01, 2017 - There is little indication of reporting bias in the papers, and in fact the only instance in which funding … Study outcomes information had highest number of discrepancies, potentially indication selective reporting

193. Cer-243-Prehospital-Airway-Management-Appendix-F-1 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
     January 01, 2016 - vs. pediatric: 1.80 (95% CI 1.49–2.17) pediatric vs. adult: AOR 0.56 (95% CI 0.46 to 0.67), p<0.05 Indication … Adult: 84.6% vs. 89.8% AOR, adult vs. pediatric: 1.63 (95% CI 0.70–3.31) Indication, drug assistance, … association between success rates and patient gender, body mass index, age, cervical spine immobilization, indication … Patient gender, body mass index, age, cervical spine immobilization, indication for airway management … 0.82 (95% CI 0.40 to 1.70), p=0.60 Age, sex, intubation experience, trauma type, drugs administered, indication

194. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository Evidence Base (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-6-protocol.pdf
     December 07, 2024 - Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository Evidence Base Evidence-based Practice Center Systematic Review Protocol Project Title: Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Re…

195. Cer-238-Cervical-Ripening-Appendix-E-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-2.xlsx
     January 01, 2017 - differences in Bishop score (stat sig); although not stat significant >10% diff in parity; Differences in indication … remain [statistically significant] after controlling for maternal age, parity, BMI, gestational age and indication … Logistic regression controlling for "maternal demographic and induction indication variables" done for

196. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
     April 01, 2022 - opioid discontinuation or dose reductions were unknown, and findings are susceptible to confounding by indication … Studies could not evaluate the indication or circumstances for dose reduction, or discontinuation … limitations.7 However, results are potentially susceptible to residual confounding related to the indication … due to the observational design are potentially susceptible to residual confounding related to the indication … circumstances of dose reductions or discontinuations were unknown, with potential for confounding by indication

197. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
     October 01, 2015 - However, patients with IPF have the highest waiting-list mortality rate of any indication for lung … FDA approved XPS in August 2014 under the humanitarian device exemption program; the indication is … patient population and differences in efficacy compared with ivacaftor used according to its current indication … However, patients with IPF have the highest waiting-list mortality rate of any indication for lung

198. Major-Depressive-Disorder Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
     December 01, 2015 - 1 Comparative Effectiveness Review Number 161 Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder Executive Summary Background Major depressive disorder (MDD)1 is the most prevalent and disabling form of depression, affecting more than 16 percent of U.S…

199. uterine-fibroids-protocol-160301 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
     March 01, 2016 - uterine-fibroids-protocol-160301   Source: www.effectivehealthcare.ahrq.gov Published online: March 1, 2016 Evidence-based Practice Center Systematic Review Protocol Project Title: Management of Uter ine Fibroids I. Background and Objectives for the Systematic Review Topic background Most women will dev…

200. Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
     January 01, 2024 - Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update Comparative Effectiveness Review Number 250 Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update Exec…